Fintel reports that on December 12, 2025, Citigroup maintained coverage of Herbalife (NYSE:HLF) with a Buy recommendation.
Herbalife (HLF) just gave investors a fresh reality check, with shrinking unit sales, muted demand forecasts, and regulatory worries keeping sentiment cautious despite a recent upgrade that briefly ...
TipRanks on MSN
Herbalife price target raised to $17 from $11 at Citi
Citi raised the firm’s price target on Herbalife (HLF) to $17 from $11 and keeps a Buy rating on the shares after meeting with management. The ...
Herbalife Nutrition Ltd (HLF) stock reached a significant milestone, hitting a 52-week high at 13.39 USD. This marks a substantial increase in the stock’s performance, with an impressive 87.89% ...
StockStory.org on MSN
Why Herbalife (HLF) Stock Is Trading Up Today
Shares of health and wellness products company Herbalife (NYSE:HLF) jumped 10.8% in the afternoon session after Argus Research upgraded its rating on the company's stock to 'Buy' from 'Hold' and set a ...
Investing.com - Mizuho raised its price target on Herbalife (NYSE:HLF) to $11.00 from $10.00 while maintaining a Neutral rating on the stock. Herbalife is currently trading at $11.83, having surged ...
StockStory.org on MSN
Q3 Earnings Highs And Lows: Herbalife (NYSE:HLF) Vs The Rest Of The Personal Care Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
24/7 Wall St. on MSN
Top Insider Purchases in December Signal Market Confidence
December has brought big insider purchases in shares of GE Aerospace and others. That was not the only notable insider buying ...
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
11d
Carl Icahn
Activist investor Carl Icahn has tightened his hold on pharmaceutical company Bausch Health. Dana has entered an agreement to add two new board members picked by Carl Icahn’s company, one of whom is ...
StockStory.org on MSN
Q3 Earnings Roundup: Estée Lauder (NYSE:EL) And The Rest Of The Personal Care Segment
Detailed price information for Estee Lauder Companies (EL-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback